Dose Escalation Study of TAB08 in Patients With Advanced Solid Neoplasms
Clinical trial NCT03006029 · COMPLETED
Trial details
- NCT number
- NCT03006029
- Sponsor
- Theramab LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-08
- Primary completion
- 2019-05-14
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.